Weight-loss drugs could help ease migraine pain and reduce asthma symptoms, new studies suggest. Experts said that people using the drugs had reported a reduction in asthma flare-ups and inhaler use. And another study has linked Wegovy to fewer prescriptions for migraine medication among women taking the drugs for weight loss.
The studies, presented to the European Congress On Obesity in Turkey, add to a body of evidence which suggest glucagon-like peptide-1 receptor agonist (GLP-1RA) drugs may have benefits beyond weight loss. In England, they are already being prescribed to help cut the risk of heart attacks and strokes.
Now a new study has linked Wegovy to a reduction in prescriptions for a type of migraine medication. Experts examined Danish health registries between 2022 and 2024, including data on 150,000 people who started Wegovy. Of these, some 6,800 had a prescription for migraine medicine in the year before they started weight-loss treatment.
